Renal replacement therapy in Europe : A summary of the 2012 ERA-EDTA Registry Annual Report

Simple item page
dc.contributor.authorEuropean Renal Association–European Dialysis and Transplant Association (ERA-EDTA)
dc.contributor.authorCernevskis, Harijs
dc.contributor.institutionDepartment of Internal Diseases
dc.date.accessioned2021-09-16T20:00:01Z
dc.date.available2021-09-16T20:00:01Z
dc.date.issued2015-06
dc.descriptionPublisher Copyright: © The Author 2015.
dc.description.abstractBackground. This article summarizes the 2012 European Renal Association-European Dialysis and Transplant Association Registry Annual Report (available at www.era-edta-reg.org) with a specific focus on older patients (defined as ≥65 years). Methods. Data provided by 45 national or regional renal registries in 30 countries in Europe and bordering the Mediterranean Sea were used. Individual patient level data were received from 31 renal registries, whereas 14 renal registries contributed data in an aggregated form. The incidence, prevalence and survival probabilities of patients with end-stage renal disease (ESRD) receiving renal replacement therapy (RRT) and renal transplantation rates for 2012 are presented. Results. In 2012, the overall unadjusted incidence rate of patients with ESRD receiving RRT was 109.6 per million population (pmp) (n = 69 035), ranging from 219.9 pmp in Portugal to 24.2 pmp in Montenegro. The proportion of incident patients ≥75 years varied from 15 to 44% between countries. The overall unadjusted prevalence on 31 December 2012 was 716.7 pmp (n = 451 270), ranging from 1670.2 pmp in Portugal to 146.7 pmp in the Ukraine. The proportion of prevalent patients ≥75 years varied from 11 to 32% between countries. The overall renal transplantation rate in 2012 was 28.3 pmp (n = 15 673), with the highest rate seen in the Spanish region of Catalonia. The proportion of patients ≥65 years receiving a transplant ranged from 0 to 35%. Five-year adjusted survival for all RRT patients was 59.7% (95% confidence interval, CI: 59.3-60.0) which fell to 39.3% (95% CI: 38.7-39.9) in patients 65-74 years and 21.3% (95% CI: 20.8-21.9) in patients ≥75 years.en
dc.description.statusPeer reviewed
dc.format.extent14
dc.format.extent1250615
dc.identifier.citationEuropean Renal Association–European Dialysis and Transplant Association (ERA-EDTA) & Cernevskis, H 2015, 'Renal replacement therapy in Europe : A summary of the 2012 ERA-EDTA Registry Annual Report', Clinical Kidney Journal, vol. 8, no. 3, pp. 248-261. https://doi.org/10.1093/ckj/sfv014
dc.identifier.doi10.1093/ckj/sfv014
dc.identifier.issn2048-8505
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/6375
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=84940437459&partnerID=8YFLogxK
dc.language.isoeng
dc.relation.ispartofClinical Kidney Journal
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectEnd-stage renal disease
dc.subjectIncidence
dc.subjectPrevalence
dc.subjectRenal replacement therapy
dc.subjectSurvival
dc.subject3.2 Clinical medicine
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database
dc.subjectNephrology
dc.subjectTransplantation
dc.titleRenal replacement therapy in Europe : A summary of the 2012 ERA-EDTA Registry Annual Reporten
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Renal_replacement_therapy_in_Europe_summary_2012.pdf
Size:
1.19 MB
Format:
Adobe Portable Document Format
Download

Collections

Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure